JPS56501453A - - Google Patents

Info

Publication number
JPS56501453A
JPS56501453A JP50013880A JP50013880A JPS56501453A JP S56501453 A JPS56501453 A JP S56501453A JP 50013880 A JP50013880 A JP 50013880A JP 50013880 A JP50013880 A JP 50013880A JP S56501453 A JPS56501453 A JP S56501453A
Authority
JP
Japan
Prior art keywords
enzyme mixture
protein
units
solution
activity per
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP50013880A
Other languages
English (en)
Japanese (ja)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/091,041 external-priority patent/US4286064A/en
Application filed filed Critical
Publication of JPS56501453A publication Critical patent/JPS56501453A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4873—Cysteine endopeptidases (3.4.22), e.g. stem bromelain, papain, ficin, cathepsin H
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/66—Enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/10—Washing or bathing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/28—Rubbing or scrubbing compositions; Peeling or abrasive compositions; Containing exfoliants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Transceivers (AREA)
JP50013880A 1979-11-05 1980-10-24 Pending JPS56501453A (enrdf_load_stackoverflow)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9104079A 1979-11-05 1979-11-05
US06/091,041 US4286064A (en) 1979-11-05 1979-11-05 Process for isolating active debriding agent from bromelain

Publications (1)

Publication Number Publication Date
JPS56501453A true JPS56501453A (enrdf_load_stackoverflow) 1981-10-08

Family

ID=26783198

Family Applications (1)

Application Number Title Priority Date Filing Date
JP50013880A Pending JPS56501453A (enrdf_load_stackoverflow) 1979-11-05 1980-10-24

Country Status (5)

Country Link
EP (1) EP0039726A4 (enrdf_load_stackoverflow)
JP (1) JPS56501453A (enrdf_load_stackoverflow)
AU (1) AU543965B2 (enrdf_load_stackoverflow)
CA (1) CA1156931A (enrdf_load_stackoverflow)
WO (1) WO1981001242A1 (enrdf_load_stackoverflow)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2019508392A (ja) * 2016-01-31 2019-03-28 メディウーンド リミテッド 創傷を治療するためのデブリードマン組成物
JP2019511581A (ja) * 2016-04-18 2019-04-25 メディウンド リミテッド 慢性創傷の壊死組織除去法

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8724728D0 (en) * 1987-10-22 1987-11-25 Genzyme Corp Cysteine proteinase
IL165334A0 (en) 2004-11-22 2006-01-15 Mediwound Ltd Debriding composition from bromelain and methods of producing same
ITMI20052076A1 (it) 2005-10-31 2007-05-01 Stel S N C Dell Ing Ermete Riva & C Apparecchiatura per il trattamento endotonico mediante circolazione di soluzioni enzimatiche nella camera pulpare e nei canali radicolari
CN113679828A (zh) * 2021-08-25 2021-11-23 佛山市第一人民医院（中山大学附属佛山医院） 一种伤口清洗液及其制备方法和应用
CN114107265B (zh) * 2021-11-05 2023-12-01 罗钰玲 一种提取菠萝蛋白酶的工艺

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3446706A (en) * 1966-01-27 1969-05-27 Jack F Beuk Process of producing plant proteases
US3446626A (en) * 1966-08-25 1969-05-27 John K Mcanelly Method for preparing a bromelain solution for ante-mortem injection
US3442764A (en) * 1966-09-12 1969-05-06 Swift & Co Process of purifying bromelain
US4197291A (en) * 1974-01-08 1980-04-08 Gerold K. V. Klein Hydrolytic enzyme material

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2019508392A (ja) * 2016-01-31 2019-03-28 メディウーンド リミテッド 創傷を治療するためのデブリードマン組成物
JP2019511581A (ja) * 2016-04-18 2019-04-25 メディウンド リミテッド 慢性創傷の壊死組織除去法

Also Published As

Publication number Publication date
EP0039726A1 (en) 1981-11-18
AU6573480A (en) 1981-05-22
AU543965B2 (en) 1985-05-09
WO1981001242A1 (en) 1981-05-14
CA1156931A (en) 1983-11-15
EP0039726A4 (en) 1982-09-27

Similar Documents

Publication Publication Date Title
Anfinsen et al. Studies on the reduction and re-formation of protein disulfide bonds
KR870002878A (ko) 콘택트 렌즈를 동시에 세척 및 소독하는 방법 및 조성물
ZA908599B (en) A method for isolating biologically active compounds
Malemud et al. Identification of neutral proteases in human neutrophil granules that degrade articular cartilage proteoglycan
JPS56501453A (enrdf_load_stackoverflow)
Uitto et al. Activation of human leukocyte collagenase by compounds reacting with sulfhydryl groups
ES2113855T3 (es) Composicion de limpieza a ph controlado para la eliminacion de proteinas.
GR1001480B (el) Ενζυμικά σκευάσματα περιέχοντα παπαϊνη ή χυμο?ρυψίνη και μέ?οδοι μόνιμης ενζυμικής αποτρίχωσης.
Samuni et al. Biphasic kinetics induced by modified substrates of penicillinase
ES2060202T3 (es) Composicion detergente enzimatica liquida.
ES486924A1 (es) Procedimiento para la purificacion de emulsionantes no ioni-cos
NO174111C (no) Fremgangsmåte for rensing av vevsplasminogenaktivatorer (t-PA)
GB1480867A (en) Protease-free kallikrein solutions a process for their preparation from purified kallikrein and their use as medicaments
Yeung et al. Effect of immobilization on stability and properties of N-acetyl-β-d-hexosaminidase from Turbo cornutus
Hamamoto et al. Comparison of effects of protein kinase C inhibitors on phorbol ester-induced CD4 down-regulation and augmentation of human immunodeficiency virus replication in human T cell lines
KR890701733A (ko) 신규 인체 조직형 플리스미노겐 활성제 변이체
GB1228698A (enrdf_load_stackoverflow)
Heinle et al. The binding of Evans blue to collagen and elastin in elastic tissue
Gomez-Lira et al. Effects of butyrate upon the metaphase-specific deacetylation of histone H4
Han et al. A simple method for removal of AMP contamination from NADP+ for the assay of muscle fructose 1, 6-bisphosphatase
FR2674536B1 (fr) Procede d'inactivation de virus et composition pharmaceutique pour l'inactivation de virus.
SU1445159A1 (ru) Способ поверхностного модифицирования резины
Shaw et al. Porcine granulosa cell production of plasminogen activator: disparity between the effects of hCG and pFSH
Scheff et al. Dehydrogenase activity of Borrelia recurrentis
Roberts et al. The Effects of Biguanides on Thrombokinase, Thrombin and Trypsin